New APA guideline hones in on hard-to-treat depression patients
Final guidance on clopidogrel and dipyridamole from NICE
Drug shortages frustrating pharmacists in North America
WHO's malaria strategy "the best in decades"
NICE rejects bevacizumab due to high cost, small benefits
US Medicaid pharmacy could save big bucks through new approach
New WHO guidelines spell out steps to preventing TB in HIV
Sedation guidelines for children: first-time ever in the UK
Updated CDC guidelines for the prevention of perinatal GBS
Prucalopride recommended for chronic constipation by NICE
UK NICE has issued final guidance to the NHS recommending against the use of bevacizumab
Tens of millions are being wasted each year as "clever marketing" strategies, by the pharmaceutical industry, drive the push for analogue insulins in the NHS.
In the face of cost cutting, the UK's leading neurosurgeons are asking why costly neurosurgical instruments are being thrown away
Cancer care in the UK does not match the best in Europe, which is costing the UK 10 000 lives per year, the national clinical director for cancer
Vaccine studies show advances in health economic research
European AF patients at risk due to missed opportunities
Age, insurance status, affects site of care in sickle-cell anaemia
Drop in reimbursement led to drop in inappropriate ADT use
High deductibles force lower-income families to forgo care
Best options for asthma treatment?
Nurse-only triage for pharyngitis "safe and cost-effective"
Conventional cervical cancer surveillance proves best
What factors influence prescription abandonment at the pharmacy?
Dabigatran: an alternative to warfarin despite higher cost?
Insulin aspart wins out over insulin glargine in China
Critical limb ischaemia: "expensive" to treat
HF clinics cost effective in Canada
Antidepressant use common in diabetics
Dihydrocodeine spells better global QOL than tramadol
Infliximab prior to adalimumab creates good QOL gains in CD
Ritonavir-boosted atazanavir: cost-effective first-line HIV therapy
DRV/r monotherapy switch could save Spain euro22 million
New, high-cost gout therapies set to inflate market
The individual mandate, requiring all US citizens to have health insurance, has been ruled "unconstitutional" by a Virginian judge, Henry Hudson,
Asthma drug market in India heading for swift growth
Over 200 leading doctors say that the NHS reforms will destroy the health service by "liberating the NHS's £100bn budget to commercial enterprises".